Reducing Opioid Utilization After Ureteroscopy Without Compromising Patient Outcomes in a Statewide Quality Improvement Collaborative
Opioid use after ureteroscopy has declined sharply in Michigan. We did not see evidence that PROs differed between patients discharged opioid-free who later required rescue opioids and those discharged with opioids, supporting the use of multimodal regimens. Postoperative stent use, however, was a key predictor of pain, highlighting its modifiable impact on outcomes.
Authors
- Golena Fernández Moncaleano
- Wilson Sui (ORCID: https://orcid.org/0000-0002-1819-6596)
- Suprita Krishna
- David Wenzler (ORCID: https://orcid.org/0000-0002-2370-5690)
- Karla Witzke
- Brian Seifman
- Caitlin Seibel
- Russell Becker
- Hector Pimentel
- Casey Dauw
- Andrew M. Higgins
- Khurshid R. Ghani
Institutions
- University of Michigan (US)
- MidMichigan Medical Center - Midland (US)
- Michigan Institute of Urology (US)
- Michigan Medicine (US)
- Comprehensive Urology (US)
- Corewell Health
Publication Details
- Journal
- Urology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1016/j.urology.2025.12.044
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation
- Cook Medical
- Coloplast